Security key
40423R105
- Security type / class
- Equity / COM
- Total 13F shares
- 1,212,337
- Total 13F value
- $784,300
- Share change
- +112,227
- SEC-reported price per share
- $0.65
- Number of holders
- 18
- Value change
- +$72,457
- Number of buys
- 7
- Number of sells
- 7
Report period
Q2 2024
Institutions
18
Top holders
10
HCWB full security history
Ownership snapshot
Full 13F holder table
HCW Biologics Inc. SEC filings
HCW Biologics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of HCWB - HCW Biologics Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HighTower Advisors, LLC
Disclosed value leader
HighTower Advisors, LLC
Comparable rows
0/15
Latest evidence
14 Jun 2024
13F
3/4/5
Highest disclosed value: $316,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
HighTower Advisors, LLC has the largest disclosed position value at $316K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HighTower Advisors, LLC's linked filing trail.
Disclosed position value
Top 5
HighTower Advisors, LLC
$316K
Avantax Planning Partners, Inc.
$314.6K
GEODE CAPITAL MANAGEMENT, LLC
$291.1K
Cresset Asset Management, LLC
$231K
Peter Rhode
$161.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HighTower Advisors, LLC |
13F
Company
|
—
class O/S missing
|
$316,000
179,810 shares
|
— | 31 Mar 2024 |
| Avantax Planning Partners, Inc. |
13F
Company
|
—
class O/S missing
|
$314,610
179,777 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$291,132
174,284 shares
|
— | 31 Mar 2024 |
| Cresset Asset Management, LLC |
13F
Company
|
—
class O/S missing
|
$230,983
131,990 shares
|
— | 31 Mar 2024 |
| Peter Rhode |
3/4/5
Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations.
|
—
mixed-class rows
|
$161,061
136,354 shares
mixed-class rows
|
— | 11 Dec 2023 |
| Pullen Investment Management, LLC |
13F
Company
|
—
class O/S missing
|
$148,953
85,116 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
1,212,337
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
19
Q2 2024 holders
18
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|